Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tighe

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Cell Science|July 28, 2005
Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20Christopher J Morrow, Anthony Tighe, Victoria L Johnson, et al.
The Journal of Cell Biology|July 14, 2010
Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complexLaura Hewitt, Anthony Tighe, Stefano Santaguida, et al.
Royal Society Open Science|December 20, 2021
Inhibitors of the Bub1 spindle assembly checkpoint kinase: synthesis of BAY-320 and comparison with 2OH-BNPP1Ilma Amalina, Ailsa Bennett, Helen Whalley, et al.
NAR Cancer|November 16, 2022
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitorsAnya Golder, Louisa Nelson, Anthony Tighe, et al.
The Journal of Cell Biology|April 30, 2003
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochoresClaire Ditchfield, Victoria L Johnson, Anthony Tighe, et al.
Genome Medicine|September 2, 2021
Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypesBethany M Barnes, Louisa Nelson, Anthony Tighe, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instabilityLouisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine|June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancerAnthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience|June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYCSamantha Littler, Bethany M Barnes, Rhys Owen, et al.
Journal of Cell Science|January 8, 2010
Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein FMark D J Gurden, Andrew J Holland, Wouter van Zon, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Cell Science|July 28, 2005
Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20Christopher J Morrow, Anthony Tighe, Victoria L Johnson, et al.
The Journal of Cell Biology|July 14, 2010
Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complexLaura Hewitt, Anthony Tighe, Stefano Santaguida, et al.
Royal Society Open Science|December 20, 2021
Inhibitors of the Bub1 spindle assembly checkpoint kinase: synthesis of BAY-320 and comparison with 2OH-BNPP1Ilma Amalina, Ailsa Bennett, Helen Whalley, et al.
NAR Cancer|November 16, 2022
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitorsAnya Golder, Louisa Nelson, Anthony Tighe, et al.
The Journal of Cell Biology|April 30, 2003
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochoresClaire Ditchfield, Victoria L Johnson, Anthony Tighe, et al.
Genome Medicine|September 2, 2021
Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypesBethany M Barnes, Louisa Nelson, Anthony Tighe, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instabilityLouisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine|June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancerAnthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience|June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYCSamantha Littler, Bethany M Barnes, Rhys Owen, et al.
Journal of Cell Science|January 8, 2010
Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein FMark D J Gurden, Andrew J Holland, Wouter van Zon, et al.
Pageof 3